FATE THERAPEUTICS INC (FATE:NASDAQ)

$2.08 -0.09 (-4.1475%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 79

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed FATE THERAPEUTICS INC (FATE:NASDAQ) News Sources

Fate Therapeutics to Present Preliminary Clinical Data of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Sclerosis at the ISSCR 2026 Annual Meeting

06-07-2026

yahoo.com

external link

Fate Therapeutics Receives FDA Clearance of Investigational New Drug Application for FT839 Product Candidate

09-07-2026

yahoo.com

external link

Fate Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates

13-08-2026

yahoo.com

external link

Fate Therapeutics (FATE) Reports Q2 Loss, Tops Revenue Estimates

13-08-2026

yahoo.com

external link

Fate Therapeutics to Participate in Fireside Chat at the 2026 Annual Cantor Global Healthcare Conference

03-09-2026

yahoo.com

external link

Fate Therapeutics Announces Receipt of California Institute for Regenerative Medicine (CIRM) CLIN2 Grant to Advance RECLAIM-LN

25-09-2026

yahoo.com

external link

Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences

01-10-2026

yahoo.com

external link

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

02-10-2026

yahoo.com

external link

Fate Therapeutics Appoints Jamie Harrell as Senior Vice President, Market Development & Commercial Operations to Lead the Commercialization of CAR T-cell Therapies

12-10-2026

yahoo.com

external link

Fate Therapeutics Presents Updated Preliminary Data for FT819 in Active Lupus Nephritis at American Society of Nephrology Kidney Week 2026

26-10-2026

yahoo.com

external link

FATE THERAPEUTICS INC (FATE:NASDAQ) Sentiment Trend

0 25 50 75 100 90 80 89 22 89 80 87 90 88 72 06-07-2026 09-07-2026 13-08-2026 03-09-2026 25-09-2026 01-10-2026 02-10-2026 12-10-2026 26-10-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

FATE THERAPEUTICS INC (FATE:NASDAQ) FAQs

toggle

What is the current price of FATE THERAPEUTICS INC (FATE:NASDAQ)?

The current price of FATE THERAPEUTICS INC (FATE:NASDAQ) is $2.08.


toggle

FATE THERAPEUTICS INC (FATE:NASDAQ) absolute price change since previous trading day?

The absolute price change of FATE THERAPEUTICS INC (FATE:NASDAQ) since the previous trading day is $-0.09.


toggle

FATE THERAPEUTICS INC (FATE:NASDAQ) percentage price change since previous trading day?

The percentage price change of FATE THERAPEUTICS INC (FATE:NASDAQ) since the previous trading day is -4.1475%.


toggle

What is the most recent average sentiment score for FATE THERAPEUTICS INC (FATE:NASDAQ)?

The most recent average sentiment score for FATE THERAPEUTICS INC (FATE:NASDAQ) is 79 out of 100.


toggle

What is the most recent average sentiment for FATE THERAPEUTICS INC (FATE:NASDAQ)?

The most recent sentiment for FATE THERAPEUTICS INC (FATE:NASDAQ) is .


SEC-8K** Filing Available For FATE THERAPEUTICS INC (FATE:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Similar Securities People Also Ask

TTRX (Turn Therapeutics Inc)
TRDA (Entrada Therapeutics Inc)
RNTX (Rein Therapeutics Inc)

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.